OOIR: Observatory of International Research

Papers

(The H4-Index of World Journal of Gastroenterology is 48. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
SARS-CoV-2 infection in people with pre-existing liver disease: Further research is warranted	368
Leveraging machine learning for early recurrence prediction in hepatocellular carcinoma: A step towards precision medicine	346
Unresolved conundrum of the role of physical activity in irritable bowel disease: What next?	254
Colorectal motility patterns and psychiatric traits in functional constipation and constipation-predominant irritable bowel syndrome: A study from China	238
Liquid biopsy for gastric cancer: Techniques, applications, and future directions	184
Comment on “Prognostic value of preoperative enhanced computed tomography as a quantitative imaging biomarker in pancreatic cancer”	159
Suberoylanilide hydroxamic acid upregulates reticulophagy receptor expression and promotes cell death in hepatocellular carcinoma cells	139
Systemic treatment for metastatic colorectal cancer	124
Gastroesophageal reflux after per-oral endoscopic myotomy: Management literature	111
Establishment and validation of an adherence prediction system for lifestyle interventions in non-alcoholic fatty liver disease	108
Carcinoid syndrome caused by a pulmonary carcinoid mimics intestinal manifestations of ulcerative colitis: A case report	107
Very early onset perinatal constipation: Can it be cow’s milk protein allergy?	100
Gastroesophageal reflux following peroral endoscopic myotomy for achalasia: Bumps in the road to success	99
Downregulation of TNFR2 decreases survival gene expression, promotes apoptosis and affects the cell cycle of gastric cancer cells	95
Amoxicillin high-dose dual therapy for Helicobacter pylori primary eradication: Proton pump inhibitor and potassium-competitive acid blocker, which’s better?	90
Link between pharyngeal acid reflux episodes and the effectiveness of proton pump inhibitor therapy	89
Divergent trajectories of lean vs obese non-alcoholic steatohepatitis patients from listing to post-transplant: A retrospective cohort study	88
Role of one-step nucleic acid amplification in colorectal cancer lymph node metastases detection	87
Three-dimensional location approach with silk thread guided hepatectomy for liver tumor	78
Perianal fistulizing Crohn’s disease: Mechanisms and treatment options focusing on cellular therapy	77
Improving early diagnosis of multiple endocrine neoplasia type 1 by assessing the gastrointestinal symptoms, hypercalcemia, and elevated serum gastrin	76
Prognostic impact and reasons for variability by tumor location in gastric cancer	73
Back to the drawing board: Overview of the next generation of combination therapy for inflammatory bowel disease	71
Involvement of nitrergic neurons in colonic motility in a rat model of ulcerative colitis	70
Molecular mechanisms implicated in SARS-CoV-2 liver tropism	69

Intestinal flora was associated with occurrence risk of chronic non-communicable diseases	68
Endoscopic intramural cystogastrostomy for treatment of peripancreatic fluid collection: A viewpoint from a surgeon	64
Return to work in young and middle-aged colorectal cancer survivors: Factors influencing self-efficacy, fear, resilience, and financial toxicity	64
Parasites of the liver: A global problem?	61
Prostaglandin F_2α synthase promotes oxaliplatin resistance in colorectal cancer through prostaglandin F_2α-dependent and F_2α-independent mechanism	61
Knowledge and attitudes towards the use of histological assessments in ulcerative colitis by gastroenterologists vs pathologists	60
Development and validation of a nomogram for preoperative prediction of tumor deposits in colorectal cancer	60
Diagnostic role of transient elastography in patients with autoimmune liver diseases: A systematic review and meta-analysis	58
Gastric pentadecapeptide BPC 157 in cytoprotection to resolve major vessel occlusion disturbances, ischemia-reperfusion injury following Pringle maneuver, and Budd-Chiari syndrome	57
Factors other than fibrosis that increase measured shear wave velocity	55
Role of gadoxetic acid-enhanced liver magnetic resonance imaging in the evaluation of hepatocellular carcinoma after locoregional treatment	55
Modern drug discovery for inflammatory bowel disease: The role of computational methods	55
Examining dietary interventions in Crohn’s disease	53
Study of the roles of caspase-3 and nuclear factor kappa B in myenteric neurons in a P2X7 receptor knockout mouse model of ulcerative colitis	53
Presentation, patterns and predictive value of baseline liver tests on outcomes in COVID-19 patients without chronic liver disease	53
Relationship between clinical remission of perianal fistulas in Crohn’s disease and serum adalimumab concentrations: A multi-center cross-sectional study	52
Advances in paediatric nonalcoholic fatty liver disease: Role of lipidomics	52
Fibroblast growth factor 15, induced by elevated bile acids, mediates the improvement of hepatic glucose metabolism after sleeve gastrectomy	50
Survival-associated alternative splicing events interact with the immune microenvironment in stomach adenocarcinoma	50
Non-cirrhotic hepatocellular carcinoma in chronic viral hepatitis: Current insights and advancements	50
Management of Flood syndrome: What can we do better?	49
Risk factors and a predictive nomogram for lymph node metastasis in superficial esophageal squamous cell carcinoma	49
Machine learning algorithms reveal gut microbiota signatures associated with chronic hepatitis B-related hepatic fibrosis	48
BanXiaXieXin decoction treating gastritis mice with drug-resistant Helicobacter pylori and its mechanism	48